• Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#, Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, American Invents Act
• Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#, Genomics and Personalized Medicine Act; No Bill#, Genomic Research and Accessibility Act; No Bill#, BETTER Patient Care Act; HR 1249, America Invents Act

Duration: July 21, 2008 to June 30, 2011

General Issues: Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Science/Technology, Insurance

Spending: about $270,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Natl Institute of Standards & Technology (NIST), Food & Drug Administration (FDA),, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Senate, House of Representatives, Health & Human Services, Dept of (HHS)